A recent issue of Future Pharmaceuticals magazine included a Special Feature Interview and Podcast with Dr. Donald N. Halbert, Executive Vice President of Research and Development for Iconix Biosciences. In the article, Dr. Halbert discussed the benefits of Toxicogenomics, and offered his thoughts on how pharmaceutical companies can utilize this technology to improve safety and reduce costs of drug discovery.

View the full text of his interview from the magazine and listen to the Executive Podcast interview he recorded with Priya Rehal, Future Pharmaceuticals’ managing editor, by clicking the links below. For more information about Future Pharmaceuticals, visit their website at www.futurepharmaus.com.

"Target: Toxicity" from Future Pharmaceuticals Magazine [PDF]

Executive Podcast interview with Dr. Donald N. Halbert [MP3]